Why the study?
Evaluating the quality of human recombinant ANP and BNP compared to conventional treatment in heart failure requires more clinical trials.
Answers are grounded in this paper and cite their sources.
The abstract highlights the physiological role of natriuretic peptides in heart failure and suggests that human recombinant ANP and BNP require further clinical trials to evaluate their therapeutic potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Saadh et al. (2021) conducted a review in Heart failure. Human recombinant ANP and BNP vs. Conventional treatment was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: